You cannot know the power of an investment unless you see the returns. Many think of dividend stocks as a way of generating ...

Pfizer's Q3 earnings fell, but the company still raised its full-year earnings guidance. Major cost reductions remain on ...

Discover why Pfizer Inc. is rated a Strong Buy with 33% upside, robust dividends, and growth prospects ahead. Click for my updated look at PFE stock.

Pfizer offers a 7% dividend yield, lower COVID sales, oncology and cardiometabolic focus, and growth from Metsera and ...

Jon Smith explains why investors can look across the pond for stocks with attractive dividend forecasts and shares a specific ...

We also have a huge number of stocks that are sinking under their own weight, high-quality companies, real companies that are ...

Boomers today are between 60 and 79 years old. You may be just a few years away from retirement, or it has been over a decade ...

In September, the telecommunications giant announced it was boosting its dividend by 1.25 cents a share to $0.69 per share, ...

Pfizer currently has a 7% yield, and the company is making important business moves. Bristol Myers Squibb has a 5.6% yield ...

Nutrien (NTR) declares $0.545/share quarterly dividend, in line with previous. Forward yield 4.04% Payable Jan. 16; for ...

A second magnificent ultra-high-yield dividend stock that's begging to be bought in November is pharmaceutical titan Pfizer ...

Pfizer Inc. (NYSE:PFE) is a‌ major US pharmaceutical and biotech‍n‍ology company that‌ offers a wide rang‌e⁠ o‌f products and services. In rec‌ent years, the company has experienced declini‍ng rev ...